| . | Baseline (N = 154) . | Follow-up (N = 154) . | P-value . |
|---|---|---|---|
| Total plaque volume (mm³) | 475 (173–902) | 514 (190–1030) | <0.001 |
| Calcified plaque volume (mm³) | 30 (10–70) | 74 (21–150) | <0.001 |
| Non-calcified plaque volume (mm³) | 420 (162–822) | 417 (179–784) | 0.030 |
| Number of plaques | 4 (1–6) | 5 (2–7) | <0.001 |
| CAD scorea | 11 (5–19) | 14 (8–21) | <0.001 |
| Maximal stenosis in all segments | |||
| No CAD | 14 (9) | 0 (0) | N/A |
| <30% | 59 (38) | 53 (34) | 0.34 |
| 30–50% | 29 (19) | 54 (35) | <0.001 |
| 50–70% | 17 (11) | 21 (14) | 0.37 |
| 70–90% | 26 (17) | 17 (11) | 0.020 |
| >90% | 8 (5) | 9 (6) | 0.71 |
| Uninterpretable | 1 (1) | 0 (0) | N/A |
| . | Baseline (N = 154) . | Follow-up (N = 154) . | P-value . |
|---|---|---|---|
| Total plaque volume (mm³) | 475 (173–902) | 514 (190–1030) | <0.001 |
| Calcified plaque volume (mm³) | 30 (10–70) | 74 (21–150) | <0.001 |
| Non-calcified plaque volume (mm³) | 420 (162–822) | 417 (179–784) | 0.030 |
| Number of plaques | 4 (1–6) | 5 (2–7) | <0.001 |
| CAD scorea | 11 (5–19) | 14 (8–21) | <0.001 |
| Maximal stenosis in all segments | |||
| No CAD | 14 (9) | 0 (0) | N/A |
| <30% | 59 (38) | 53 (34) | 0.34 |
| 30–50% | 29 (19) | 54 (35) | <0.001 |
| 50–70% | 17 (11) | 21 (14) | 0.37 |
| 70–90% | 26 (17) | 17 (11) | 0.020 |
| >90% | 8 (5) | 9 (6) | 0.71 |
| Uninterpretable | 1 (1) | 0 (0) | N/A |
Per-patient change in plaque characteristics between baseline and follow-up coronary CTA (n = 154). Values are presented as median (IQR) or n (%). Values in bold font indicate statistically significant results.
aBased on a comprehensive CTA score incorporating the presence, extent, severity, location, and composition of CAD.
N/A, not applicable.
| . | Baseline (N = 154) . | Follow-up (N = 154) . | P-value . |
|---|---|---|---|
| Total plaque volume (mm³) | 475 (173–902) | 514 (190–1030) | <0.001 |
| Calcified plaque volume (mm³) | 30 (10–70) | 74 (21–150) | <0.001 |
| Non-calcified plaque volume (mm³) | 420 (162–822) | 417 (179–784) | 0.030 |
| Number of plaques | 4 (1–6) | 5 (2–7) | <0.001 |
| CAD scorea | 11 (5–19) | 14 (8–21) | <0.001 |
| Maximal stenosis in all segments | |||
| No CAD | 14 (9) | 0 (0) | N/A |
| <30% | 59 (38) | 53 (34) | 0.34 |
| 30–50% | 29 (19) | 54 (35) | <0.001 |
| 50–70% | 17 (11) | 21 (14) | 0.37 |
| 70–90% | 26 (17) | 17 (11) | 0.020 |
| >90% | 8 (5) | 9 (6) | 0.71 |
| Uninterpretable | 1 (1) | 0 (0) | N/A |
| . | Baseline (N = 154) . | Follow-up (N = 154) . | P-value . |
|---|---|---|---|
| Total plaque volume (mm³) | 475 (173–902) | 514 (190–1030) | <0.001 |
| Calcified plaque volume (mm³) | 30 (10–70) | 74 (21–150) | <0.001 |
| Non-calcified plaque volume (mm³) | 420 (162–822) | 417 (179–784) | 0.030 |
| Number of plaques | 4 (1–6) | 5 (2–7) | <0.001 |
| CAD scorea | 11 (5–19) | 14 (8–21) | <0.001 |
| Maximal stenosis in all segments | |||
| No CAD | 14 (9) | 0 (0) | N/A |
| <30% | 59 (38) | 53 (34) | 0.34 |
| 30–50% | 29 (19) | 54 (35) | <0.001 |
| 50–70% | 17 (11) | 21 (14) | 0.37 |
| 70–90% | 26 (17) | 17 (11) | 0.020 |
| >90% | 8 (5) | 9 (6) | 0.71 |
| Uninterpretable | 1 (1) | 0 (0) | N/A |
Per-patient change in plaque characteristics between baseline and follow-up coronary CTA (n = 154). Values are presented as median (IQR) or n (%). Values in bold font indicate statistically significant results.
aBased on a comprehensive CTA score incorporating the presence, extent, severity, location, and composition of CAD.
N/A, not applicable.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
